A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease

Figure 1

Study design of the test of DA5-CH with liraglutide as a comparator. Both drugs were tested at 25 nmol/kg and 50 nmol/kg bw ip. once daily. Control mice received normal saline (NS).